Cargando…

Is a Triggering Role or a Causative Role of PD-1/PDL-1 Inhibitors in the Development of Paraneoplastic Dermatomyositis?

Detalles Bibliográficos
Autores principales:	Starace, Michela, Pampaloni, Francesca, Carpanese, Miriam Anna, Sechi, Andrea, Bruni, Francesca, Alessandrini, Aurora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464532/ https://www.ncbi.nlm.nih.gov/pubmed/36159126 http://dx.doi.org/10.5826/dpc.1203a105

Ejemplares similares

Atypical Presentation of Congenital Triangular Alopecia: A Case Series in Italy
por: Starace, Michela, et al.
Publicado: (2020)

What’s Under the Veil?
por: Starace, Michela, et al.
Publicado: (2021)

Bubble Hair and the Usefulness of Trichoscopy
por: Alessandrini, Aurora, et al.
Publicado: (2020)

The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study
por: Alessandrini, Aurora Maria, et al.
Publicado: (2021)

Paraneoplastic Wong-Type Dermatomyositis Associated with Gynecological Malignancy
por: Russo, Roberto, et al.
Publicado: (2022)

Management of malignant cutaneous wounds in oncologic patients
por: Starace, Michela, et al.
Publicado: (2022)

Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors
por: Wu, Yanping, et al.
Publicado: (2020)

Digital Ulcers: Multidisciplinary Approach and Dermatological Management
por: Starace, Michela, et al.
Publicado: (2023)

Paraneoplastic Dermatomyositis Associated with Metastatic Seminoma
por: Yoshie, Hidekazu, et al.
Publicado: (2016)

Paraneoplastic Dermatomyositis Syndrome Presenting as Dysphagia
por: Ofori, Emmanuel, et al.
Publicado: (2017)

4. A paraneoplastic case of dermatomyositis
por: Wilson-Morkeh, Harold, et al.
Publicado: (2019)

Paraneoplastic dermatomyositis in a patient with an oligodendroglioma
por: Kim, Esther, et al.
Publicado: (2019)

A pilot study of intralesional methotrexate injections versus triamcinolone acetonide in patients affected by nail matrix psoriasis
por: Starace, Michela, et al.
Publicado: (2022)

Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis
por: Didona, Dario, et al.
Publicado: (2020)

Clinical and Instrumental Objective Evidence of the Efficacy of a New Water-Based Nail-Strengthening Solution Containing Pistacia lentiscus and Hyaluronic Acid Applied for Up to 6 Months to Improve the Appearance of Weak, Brittle Nails
por: Piraccini, Bianca Maria, et al.
Publicado: (2019)

Concomitant Use of Steroids and Immunotherapy in a Patient With Paraneoplastic Dermatomyositis and Gastroesophageal Adenocarcinoma
por: Poli De Frias, Fernando, et al.
Publicado: (2023)

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
por: Sponaas, Anne-Marit, et al.
Publicado: (2015)

Multiple Skeletal Muscle Metastases from Colon Carcinoma Preceded by Paraneoplastic Dermatomyositis
por: Landriscina, Matteo, et al.
Publicado: (2013)

PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
por: Stenehjem, David D, et al.
Publicado: (2018)

Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
por: Lei, Qingyang, et al.
Publicado: (2020)

Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
por: Makuku, Rangarirai, et al.
Publicado: (2021)

PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines
por: Safi, Mohammed, et al.
Publicado: (2020)

Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond
por: Fazel, Mina, et al.
Publicado: (2023)

Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary
por: Merry, Eve, et al.
Publicado: (2020)

Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy
por: Weidhaas, Joanne, et al.
Publicado: (2022)

Immunotherapy of Ovarian Cancer with Particular Emphasis on the PD-1/PDL-1 as Target Points
por: Świderska, Janina, et al.
Publicado: (2021)

Machine-Learning Guided Discovery of Bioactive Inhibitors of PD1-PDL1 Interaction
por: Patil, Sachin P., et al.
Publicado: (2022)

Expression of PD1 and PDL1 as immune-checkpoint inhibitors in mantle cell lymphoma
por: Ameli, Fereshteh, et al.
Publicado: (2022)

Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma
por: Rigo, Valentina, et al.
Publicado: (2017)

Paraneoplastic Dermatomyositis with Carcinoma Cervix: A Rare Clinical Association
por: Kumar, Sumir, et al.
Publicado: (2014)

A Case of Paraneoplastic Dermatomyositis Presenting With Malignant Pleural Effusion
por: Upadhyay, Puja, et al.
Publicado: (2023)

Squamous cell carcinoma of the nail unit
por: Starace, Michela, et al.
Publicado: (2018)

Use of Nail Dermoscopy in the Management of Melanonychia: Review
por: Starace, Michela, et al.
Publicado: (2019)

Erosive pustular dermatosis of the scalp: challenges and solutions
por: Starace, Michela, et al.
Publicado: (2019)

Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types
por: Martin‐Romano, Patricia, et al.
Publicado: (2020)

Impact and Management of Loss of Eyebrows and Eyelashes
por: Starace, Michela, et al.
Publicado: (2023)

What role does PDL1 play in EMT changes in tumors and fibrosis?
por: Zhang, Yun-Chao, et al.
Publicado: (2023)

Paraneoplastic Dermatomyositis in Hepatocellular Carcinoma with Colonic Perforation: A Case Report
por: Miyata, Naoteru, et al.
Publicado: (2016)

Paraneoplastic Dermatomyositis in a Case of Gallbladder Signet Ring Cell Carcinoma
por: Paul, Aritra, et al.
Publicado: (2020)

Prognostic Value of BRAF, Programmed Cell Death 1 (PD1), and PD Ligand 1 (PDL1) Protein Expression in Colon Adenocarcinoma
por: Ibrahiem, Afaf T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rgtgbf09e8stk3gf9v34kkblg0